Carolyn Dulney

Carolyn Dulney has a diverse work experience in the pharmaceutical industry. Carolyn is currently working as the Global Regulatory Strategy Leader, CMC at the Bill & Melinda Gates Medical Research Institute since July 2022. Prior to this, they served as the Director/Principal Scientist, GRA CMC Biologics at Merck from January 2020 to July 2022.

From 2006 to 2020, Carolyn worked at Sanofi Pasteur in various roles within Regulatory Affairs CMC. Carolyn'sroles included Deputy Director, Bacterial Team Lead (February 2017 to January 2020), Deputy Director (March 2015 to February 2017), Manager (January 2013 to March 2015), Global Regulatory Product Manager (April 2008 to March 2013), and Research to Launch (R2L) Technician III (November 2006 to March 2008).

Before joining Sanofi Pasteur, they worked at the same company as a Research to Launch (R2L) Technician II from February 2004 to March 2006 and as a Contract Research to Launch Technician from February 2003 to February 2004.

Carolyn Dulney's education history includes attending King's College. No information is provided about the specific degree or field of study pursued, as well as the start and end years of enrollment.